Vishnu Girish
liveloveliver.bsky.social
Vishnu Girish
@liveloveliver.bsky.social
Hepatologist | Living the liver life | Advocate for free education | One liver at a time | Celebrating uniqueness, against discrimination #Liversky
ur latest in Clinical and Molecular Hepatology is out: “Tracking the trajectory of kidney dysfunction in cirrhosis: the AKI–CKD spectrum.”
time to rethink kidney injury as a continuum.

pubmed.ncbi.nlm.nih.gov/40138802/
April 1, 2025 at 6:39 AM
#GISky High lipase but no pancreatitis, what now?
Reference: PMID 38817657
February 2, 2025 at 2:13 PM
Reposted by Vishnu Girish
A new #PSC review from @f8martine.bsky.social , et al.

PSC-IBD is probably a distinct form of IBD with UC and Crohn's.

"on a molecular level, almost all people with PSC have underlying colitis"

2024 = 100th anniversary of the description of PSC

journals.lww.com/hep/abstract...

#liversky
PSC and colitis: A complex relationship : Hepatology
an extraintestinal manifestation of IBD, the clinical phenotype, genetic and intestinal microbiota associations strongly argue for PSC-IBD being a distinct form of IBD, existing alongside ulcerative c...
journals.lww.com
January 29, 2025 at 4:05 PM
Reposted by Vishnu Girish
🆕 AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals

@amergastroassn.bsky.social
#IDsky #Liversky

www.gastrojournal.org/action/showP...
January 30, 2025 at 3:56 AM
Reposted by Vishnu Girish
Admittedly the cool name of the study group first caught my 👁️

POSEIDON study group showed
✅alfapump 📉need for LVP
✅similar complications
✅improved QOL
@amcollegegastro.bsky.social

journals.lww.com/ajg/abstract...

#liversky
January 6, 2025 at 4:44 PM
Reposted by Vishnu Girish
Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Introduction Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven...
doi.org
January 7, 2025 at 7:30 AM
📢Thrilled to share our latest review article. Greatful to Prof. Rakhi Maiwall. We explore challenges of managing septic shock in cirrhosis and advocate for personalized approaches
pubmed.ncbi.nlm.nih.gov/39744868/

#liversky #Medsky #GIsky

@anandvkulkarni.bsky.social
January 4, 2025 at 2:12 AM
Reposted by Vishnu Girish
Great look into the future on HCC surveillance by George Ioannou at AASLD #TLM24

Seems likely that blood based biomarkers and aMRI will play some role but, despite its significant flaws, ultrasound has so far stood the test of time
November 16, 2024 at 2:45 PM
Reposted by Vishnu Girish
Some Resmetirom considerations @SonalKumarMD for #MASLD #MASH at #TLM24

🟢 Dosing is weight-based
🔴 Beware of drug interactions: Gemfibrozil, Plavix, and statins
🔵 Mostly GI side effects, mostly short-lived
November 17, 2024 at 10:27 PM
Reposted by Vishnu Girish
Did you know...

There are nifty one page summaries of selected ACG guidelines available at gi.org/guidelines

Just click on the "Summary" tab under the guidelines

Here are some examples with many more in development

#GISky #LiverSky
November 13, 2024 at 4:04 PM